Loomis, Sayles & Company’s PharMerica Corporation PMC Stock Holding History

Loomis, Sayles & Company’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-145,269	Closed	-$4.26M	–	988
2017 Q3	$4.26M	Sell	145,269 -326,138	-69%	-$9.14M	0.01%	531
2017 Q2	$12.4M	Sell	471,407 -4,031	-0.8%	-$99.1K	0.03%	369
2017 Q1	$11.1M	Sell	475,438 -8,703	-2%	-$215K	0.03%	400
2016 Q4	$12.2M	Sell	484,141 -1,979	-0.4%	-$50K	0.03%	393
2016 Q3	$13.6M	Sell	486,120 -13,688	-3%	-$351K	0.03%	365
2016 Q2	$12.3M	Buy	499,808 +88,618	+22%	+$2.2M	0.03%	391
2016 Q1	$9.09M	Buy	411,190 +185,055	+82%	+$4.92M	0.03%	429
2015 Q4	$7.92M	Buy	+226,135	New	+$7.08M	0.02%	452

Loomis, Sayles & Company's PMC Position: Q4 2017 in Review

Loomis, Sayles & Company sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 145,269 shares — an estimated $4.26M sold.

Loomis, Sayles & Company first reported a position in PMC in Q4 2015 and held it in 8 quarters. The position peaked at $13.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

Loomis, Sayles & Company reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
Loomis, Sayles & Company sold 145,269 PharMerica Corporation shares in Q4 2017, an estimated $4.26M.
Loomis, Sayles & Company first reported a position in PharMerica Corporation in Q4 2015 and held it in 8 quarters.
Loomis, Sayles & Company's PharMerica Corporation position peaked at $13.6M in Q3 2016.
0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Loomis, Sayles & Company's 13F filing for Q4 2017, filed 14 Feb 2018.